Log in to save to my catalogue

Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction pa...

Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction pa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1853365479

Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial

About this item

Full title

Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial

Publisher

England: Oxford University Press

Journal title

European heart journal. Cardiovascular pharmacotherapy, 2017-04, Vol.3 (2), p.92-97

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Background
Inflammation of the arterial wall plays a central role in the pathogenesis of atherosclerosis. Among patients with rheumatic diseases, anti-rheumatic medication reduces the incidence of cardiovascular (CV) diseases, but only few studies have addressed their cardioprotective effects on patients with no rheumatic diseases. Hydroxychloro...

Alternative Titles

Full title

Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1853365479

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1853365479

Other Identifiers

ISSN

2055-6837

E-ISSN

2055-6845

DOI

10.1093/ehjcvp/pvw035

How to access this item